Low-level laser therapy device for women's hair loss receives FDA approval

Aug. 27, 2015

A low-level laser therapy wearable device maker has received FDA clearance for its device developed for women's hair loss treatment.

BioOptics World Editors

Low-level laser therapy (LLLT) wearable device maker LaserCap Company (Cleveland, OH) has received FDA clearance for its LCPRO device, which was developed for women's hair loss treatment. The device, which is embedded with 224 laser diodes, can be worn discreetly under a hat and promote hair growth without surgery or drugs.

The company was co-founded in 2006 by Cleveland doctor and inventor Michael Rabin, MD; Cleveland hair restoration physician Robert Haber, MD; and Massachusetts Institute of Technology (MIT)-trained optical physicist David Smith, Ph.D., in collaboration with Harvard-based photomedicine expert Michael Hamblin, Ph.D.

The LCPRO device is available by physician only and is now being sold by over 250 doctors in more than 60 countries.

For more information, please visit www.lcpro.us.

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

About the Author

BioOptics World Editors

We edited the content of this article, which was contributed by outside sources, to fit our style and substance requirements. (Editor’s Note: BioOptics World has folded as a brand and is now part of Laser Focus World, effective in 2022.)